Description

8,13-Dihydro-1-(Methoxycarbonyl)-7H-Benz[G]Indolo[2,3-A]Quinolizin-6-Ium is a complex heterocyclic organic compound that serves as a valuable synthetic intermediate and research chemical. This compound matters for its role in the development of novel pharmacologically active molecules, particularly in the fields of medicinal chemistry and materials science. It is primarily needed by R&D laboratories, pharmaceutical development companies, and fine chemical manufacturers engaged in the synthesis of alkaloid derivatives and advanced organic structures.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of complex alkaloids and potential drug candidates targeting neurological and oncological pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and the development of new chemical entities (NCEs).
• Organic Synthesis Reagent: Serves as a versatile precursor for constructing fused polycyclic systems in advanced organic synthesis.
• Biochemical Research: Potential utility as a fluorescent probe or a ligand in biochemical assays due to its conjugated indoloquinolizine structure.
• Academic Research: Employed in university and institutional laboratories for studying heterocyclic chemistry, reaction mechanisms, and novel molecular architectures.
• Fine Chemical Production: Intermediate in the multi-step synthesis of specialty chemicals for high-value applications.

Basic Information

Product Name	8,13-Dihydro-1-(Methoxycarbonyl)-7H-Benz[G]Indolo[2,3-A]Quinolizin-6-Ium
CAS No.	23594-96-9
Molecular Formula	C₂₂H₁₈N₂O₂⁺ (typically as a salt, e.g., chloride)
Molecular Weight	342.39 g/mol (for the cation)
Synonyms	1-Carbomethoxy-8,13-dihydro-7H-benz[g]indolo[2,3-a]quinolizin-6-ium; 1-Methoxycarbonyl-8,13-dihydro-7H-benz[g]indolo[2,3-a]quinolizin-6-ium; Benz[g]indolo[2,3-a]quinolizin-6-ium, 8,13-dihydro-1-(methoxycarbonyl)-; NSC 339586; 6H-Benz[g]indolo[2,3-a]quinolizin-6-ium, 8,13-dihydro-1-(methoxycarbonyl)-; Methoxycarbonyl Cryptolepinone derivative
EINECS	Contact for details

Quality Control

Our 8,13-Dihydro-1-(Methoxycarbonyl)-7H-Benz[G]Indolo[2,3-A]Quinolizin-6-Ium is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR/LC-MS for identity confirmation, to ensure compliance with research-grade specifications. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a desiccated environment to prevent degradation. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	Yellow to orange solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.